New drug combo aims to shrink tough tonsil tumors before surgery
NCT ID NCT07353723
Summary
This study is testing a combination of two immunotherapy drugs and chemotherapy given before surgery for advanced tonsil cancer. The goal is to see if this approach can shrink tumors more effectively, potentially leading to better surgical outcomes and longer survival. The study will enroll about 10 patients to check if the treatment is safe and shows early signs of working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi Province, China
RECRUITINGShanxi, Province, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.